ZANTE GREG (Chief Financial Officer) received a stock award from VIKING THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/4/2024ACC: 0001209191-24-004231
Officer· Chief Financial Officer
Since Jan 2021
+11.57K
Net shares
Net buyer
$1.71M
Total sold
0
Open market trades
0B · 0S
2
Total transactions
31.67K acquired · 20.09K disposed
Non-Derivative Transactions2
Common Stock, par value $0.00001 per share
Direct
Shares
+31.67K
Price / share
—
Trade value
—
% of position
17.5%
3/1/2024
180.73K→212.40K
Common Stock, par value $0.00001 per share
Direct
Shares
−20.09K
Price / share
$85.22
Trade value
$1.71M
% of position
9.5%
3/1/2024
212.40K→192.30K
Total
Net shares
+11.57K
Net value
-$1.71M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share Direct | 3/1/2024 | A · Award | +31.67K | — | — | 17.5% | 180.73K | 212.40K |
| Common Stock, par value $0.00001 per share Direct | 3/1/2024 | F · Tax Withholding | −20.09K | $85.22 | $1.71M | 9.5% | 212.40K | 192.30K |
| Total | +11.57K | -$1.71M | ||||||
Derivative Transactions0
No derivative transactions reported